Anavex Life Sciences Corp (AVXL)

[falconer66a]

Not All Investors Unable to Understand the Science

I would argue that the "dynamic complexities" of CNS diseases should cause investors to be highly skeptical of the simplistic notion that "restoring cellular homeostasis" by A273 will cure CNS diseases, cancer, pain, high cholesterol, insomnia, high blood pressure, etc.

For investors unable to comprehend the complexities of the efficacies of Anavex drugs demonstrated and proven in murine subjects, they should stick, perhaps, with the most mundane of equity investments. A Microsoft, Amazon, or the like?

Those with any skepticism at all regarding Anavex in particular, and new pharmaceuticals in general, have no business in risking hard-earned dollars in equities such as AVXL.

Fact is, however, the skeptics have been selling off for how long, now? Those who thought Anavex will be a failure have liquidated their positions. Those holding, with “strong hands,” such as the several institutional owners (with substantial positions) are not “skeptical.” They comprehend both the science and profuse papers affirming the future of Anavex molecules and the company.